Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Laurel H. Messer

TitleAsst Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-BDC Pediatric
Phone303/724-6742

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Shang T, Zhang JY, Bequette BW, Raymond JK, Coté G, Sherr JL, Castle J, Pickup J, Pavlovic Y, Espinoza J, Messer LH, Heise T, Mendez CE, Kim S, Ginsberg BH, Masharani U, Galindo RJ, Klonoff DC. Diabetes Technology Meeting 2020. J Diabetes Sci Technol. 2021 Jul; 15(4):916-960. PMID: 34196228.
      View in: PubMed
    2. Messer LH, Berget C, Pyle L, Vigers T, Cobry E, Driscoll KA, Forlenza GP. Real-World Use of a New Hybrid Closed Loop Improves Glycemic Control in Youth with Type 1 Diabetes. Diabetes Technol Ther. 2021 Jun 21. PMID: 34096789.
      View in: PubMed
    3. Kudva YC, Laffel LM, Brown S, Raghinaru D, Pinsker JE, Ekhlaspour L, Levy C, Messer LH, Kovatchev B, Lum J, Beck RW, Gonder-Frederick LA. Patient Reported Outcomes in a Randomized Trial of Closed-Loop Control: The Pivotal International Diabetes Closed Loop Trial. Diabetes Technol Ther. 2021 Jun 11. PMID: 34115959.
      View in: PubMed
    4. Messer LH, Weinzimer SA. Practical Diabetes Technology: Overcoming Barriers in the Real World. Diabetes Technol Ther. 2021 Jun; 23(S2):S159-S168. PMID: 34061638.
      View in: PubMed
    5. Berget C, Akturk HK, Messer LH, Vigers T, Pyle L, Snell-Bergeon J, Driscoll KA, Forlenza GP. Real-world performance of hybrid closed loop in youth, young adults, adults and older adults with type 1 diabetes: Identifying a clinical target for hybrid closed-loop use. Diabetes Obes Metab. 2021 May 19. PMID: 34010499.
      View in: PubMed
    6. O'Malley G, Messer LH, Levy CJ, Pinsker JE, Forlenza GP, Isganaitis E, Kudva YC, Ekhlaspour L, Raghinaru D, Lum J, Brown SA. Clinical Management and Pump Parameter Adjustment of the Control-IQ Closed-Loop Control System: Results from a 6-Month, Multicenter, Randomized Clinical Trial. Diabetes Technol Ther. 2021 Apr; 23(4):245-252. PMID: 33155824.
      View in: PubMed
    7. Messer LH, Berget C, Ernst A, Towers L, Slover RH, Forlenza GP. Initiating hybrid closed loop: A program evaluation of an educator-led Control-IQ follow-up at a large pediatric clinic. Pediatr Diabetes. 2021 Jun; 22(4):586-593. PMID: 33502062.
      View in: PubMed
    8. Schoelwer MJ, Kanapka LG, Wadwa RP, Breton MD, Ruedy KJ, Ekhlaspour L, Forlenza GP, Cobry EC, Messer LH, Cengiz E, Jost E, Carria L, Emory E, Hsu LJ, Weinzimer SA, Buckingham BA, Lal RA, Oliveri MC, Kollman CC, Dokken BB, Cherñavvsky DR, Beck RW, DeBoer MD. Predictors of Time-in-Range (70-180?mg/dL) Achieved Using a Closed-Loop Control System. Diabetes Technol Ther. 2021 Jul; 23(7):475-481. PMID: 33689454.
      View in: PubMed
    9. Cobry EC, Kanapka LG, Cengiz E, Carria L, Ekhlaspour L, Buckingham BA, Hood KK, Hsu LJ, Messer LH, Schoelwer MJ, Emory E, Ruedy KJ, Beck RW, Wadwa RP, Gonder-Frederick L. Health-Related Quality of Life and Treatment Satisfaction in Parents and Children with Type 1 Diabetes Using Closed-Loop Control. Diabetes Technol Ther. 2021 Jun; 23(6):401-409. PMID: 33404325.
      View in: PubMed
    10. Forlenza GP, Buckingham BA, Brown SA, Bode BW, Levy CJ, Criego AB, Wadwa RP, Cobry EC, Slover RJ, Messer LH, Berget C, McCoy S, Ekhlaspour L, Kingman RS, Voelmle MK, Boyd J, O'Malley G, Grieme A, Kivilaid K, Kleve K, Dumais B, Vienneau T, Huyett LM, Lee JB, O'Connor J, Benjamin E, Ly TT. First Outpatient Evaluation of a Tubeless Automated Insulin Delivery System with Customizable Glucose Targets in Children and Adults with Type 1 Diabetes. Diabetes Technol Ther. 2021 Jun; 23(6):410-424. PMID: 33325779.
      View in: PubMed
    11. Zaharieva DP, Messer LH, Paldus B, O'Neal DN, Maahs DM, Riddell MC. Erratum to "Glucose Control During Physical Activity and Exercise Using Closed Loop Technology in Adults and Adolescents With Type 1 Diabetes": Canadian Journal of Diabetes 2020;44:740-749. Can J Diabetes. 2021 Feb; 45(1):96. PMID: 33500127.
      View in: PubMed
    12. Messer LH, Campbell K, Pyle L, Forlenza GP. Basal-IQ technology in the real world: satisfaction and reduction of diabetes burden in individuals with type 1 diabetes. Diabet Med. 2021 Jun; 38(6):e14381. PMID: 32767401.
      View in: PubMed
    13. Berget C, Lange S, Messer L, Forlenza GP. A clinical review of the t:slim X2 insulin pump. Expert Opin Drug Deliv. 2020 12; 17(12):1675-1687. PMID: 32842794.
      View in: PubMed
    14. Cobry EC, Berget C, Messer LH, Forlenza GP. Review of the Omnipod® 5 Automated Glucose Control System Powered by Horizon™ for the treatment of Type 1 diabetes. Ther Deliv. 2020 08; 11(8):507-519. PMID: 32723002.
      View in: PubMed
    15. Laffel LM, Kanapka LG, Beck RW, Bergamo K, Clements MA, Criego A, DeSalvo DJ, Goland R, Hood K, Liljenquist D, Messer LH, Monzavi R, Mouse TJ, Prahalad P, Sherr J, Simmons JH, Wadwa RP, Weinstock RS, Willi SM, Miller KM. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial. JAMA. 2020 06 16; 323(23):2388-2396. PMID: 32543683.
      View in: PubMed
    16. Zaharieva DP, Messer LH, Paldus B, O'Neal DN, Maahs DM, Riddell MC. Glucose Control During Physical Activity and Exercise Using Closed Loop Technology in Adults and Adolescents with Type 1 Diabetes. Can J Diabetes. 2020 Dec; 44(8):740-749. PMID: 33011134.
      View in: PubMed
    17. Messer LH, Tanenbaum ML, Cook PF, Wong JJ, Hanes SJ, Driscoll KA, Hood KK. Cost, Hassle, and On-Body Experience: Barriers to Diabetes Device Use in Adolescents and Potential Intervention Targets. Diabetes Technol Ther. 2020 10; 22(10):760-767. PMID: 32163719.
      View in: PubMed
    18. Messer LH, Weinzimer SA. Practical Implementation of Diabetes Technology: Real-World Use. Diabetes Technol Ther. 2020 Feb; 22(S1):S119-S129. PMID: 32069150.
      View in: PubMed
    19. Berget C, Messer LH, Vigers T, Frohnert BI, Pyle L, Wadwa RP, Driscoll KA, Forlenza GP. Six months of hybrid closed loop in the real-world: An evaluation of children and young adults using the 670G system. Pediatr Diabetes. 2020 03; 21(2):310-318. PMID: 31837064.
      View in: PubMed
    20. Messer LH, Berget C, Vigers T, Pyle L, Geno C, Wadwa RP, Driscoll KA, Forlenza GP. Real world hybrid closed-loop discontinuation: Predictors and perceptions of youth discontinuing the 670G system in the first 6 months. Pediatr Diabetes. 2020 03; 21(2):319-327. PMID: 31885123.
      View in: PubMed
    21. Messer LH, Sousa K, Cook PF. Applying two minds theory to self-management of Type 1 diabetes. Res Nurs Health. 2019 12; 42(6):500-508. PMID: 31587327.
      View in: PubMed
    22. Saunders A, Messer LH, Forlenza GP. MiniMed 670G hybrid closed loop artificial pancreas system for the treatment of type 1 diabetes mellitus: overview of its safety and efficacy. Expert Rev Med Devices. 2019 Oct; 16(10):845-853. PMID: 31540557.
      View in: PubMed
    23. Berget C, Messer LH, Forlenza GP. A Clinical Overview of Insulin Pump Therapy for the Management of Diabetes: Past, Present, and Future of Intensive Therapy. Diabetes Spectr. 2019 Aug; 32(3):194-204. PMID: 31462873.
      View in: PubMed
    24. Berget C, Nii P, Wyckoff L, Patrick K, Brooks-Russell A, Messer LH. Equipping School Health Personnel for Diabetes Care with a Competency Framework and Pilot Education Program. J Sch Health. 2019 Sep; 89(9):683-691. PMID: 31245846.
      View in: PubMed
    25. Messer LH, Berget C, Forlenza GP. A Clinical Guide to Advanced Diabetes Devices and Closed-Loop Systems Using the CARES Paradigm. Diabetes Technol Ther. 2019 08; 21(8):462-469. PMID: 31140878.
      View in: PubMed
    26. Ekhlaspour L, Forlenza GP, Chernavvsky D, Maahs DM, Wadwa RP, Deboer MD, Messer LH, Town M, Pinnata J, Kruse G, Kovatchev BP, Buckingham BA, Breton MD. Closed loop control in adolescents and children during winter sports: Use of the Tandem Control-IQ AP system. Pediatr Diabetes. 2019 09; 20(6):759-768. PMID: 31099946.
      View in: PubMed
    27. Forlenza GP, Ekhlaspour L, Breton M, Maahs DM, Wadwa RP, DeBoer M, Messer LH, Town M, Pinnata J, Kruse G, Buckingham BA, Cherñavvsky D. Successful At-Home Use of the Tandem Control-IQ Artificial Pancreas System in Young Children During a Randomized Controlled Trial. Diabetes Technol Ther. 2019 04; 21(4):159-169. PMID: 30888835.
      View in: PubMed
    28. Berget C, Thomas SE, Messer LH, Thivener K, Slover RH, Wadwa RP, Alonso GT. A Clinical Training Program for Hybrid Closed Loop Therapy in a Pediatric Diabetes Clinic. J Diabetes Sci Technol. 2020 03; 14(2):290-296. PMID: 30862242.
      View in: PubMed
    29. Messer LH, Cook PF, Tanenbaum ML, Hanes S, Driscoll KA, Hood KK. CGM Benefits and Burdens: Two Brief Measures of Continuous Glucose Monitoring. J Diabetes Sci Technol. 2019 11; 13(6):1135-1141. PMID: 30854886.
      View in: PubMed
    30. Forlenza GP, Kushner T, Messer LH, Wadwa RP, Sankaranarayanan S. Factory-Calibrated Continuous Glucose Monitoring: How and Why It Works, and the Dangers of Reuse Beyond Approved Duration of Wear. Diabetes Technol Ther. 2019 04; 21(4):222-229. PMID: 30817171.
      View in: PubMed
    31. Messer LH. Practical Implementation of Diabetes Technology: It Is Time. Diabetes Technol Ther. 2019 02; 21(S1):S148-S159. PMID: 30785323.
      View in: PubMed
    32. Forlenza GP, Messer LH, Berget C, Wadwa RP, Driscoll KA. Biopsychosocial Factors Associated With Satisfaction and Sustained Use of Artificial Pancreas Technology and Its Components: a Call to the Technology Field. Curr Diab Rep. 2018 09 26; 18(11):114. PMID: 30259309.
      View in: PubMed
    33. Messer LH, Berget C, Beatson C, Polsky S, Forlenza GP. Preserving Skin Integrity with Chronic Device Use in Diabetes. Diabetes Technol Ther. 2018 06; 20(S2):S254-S264. PMID: 29916740.
      View in: PubMed
    34. Messer LH. Why Expectations Will Determine the Future of Artificial Pancreas. Diabetes Technol Ther. 2018 06; 20(S2):S265-S268. PMID: 29916739.
      View in: PubMed
    35. Forlenza GP, Cameron FM, Ly TT, Lam D, Howsmon DP, Baysal N, Kulina G, Messer L, Clinton P, Levister C, Patek SD, Levy CJ, Wadwa RP, Maahs DM, Bequette BW, Buckingham BA. Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting. Diabetes Technol Ther. 2018 05; 20(5):335-343. PMID: 29658779.
      View in: PubMed
    36. Messer LH, Forlenza GP, Sherr JL, Wadwa RP, Buckingham BA, Weinzimer SA, Maahs DM, Slover RH. Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System. Diabetes Care. 2018 04; 41(4):789-796. PMID: 29444895.
      View in: PubMed
    37. Messer LH, Johnson R, Driscoll KA, Jones J. Best friend or spy: a qualitative meta-synthesis on the impact of continuous glucose monitoring on life with Type 1 diabetes. Diabet Med. 2018 Apr; 35(4):409-418. PMID: 29247556.
      View in: PubMed
    38. Breton MD, Cherñavvsky DR, Forlenza GP, DeBoer MD, Robic J, Wadwa RP, Messer LH, Kovatchev BP, Maahs DM. Closed-Loop Control During Intense Prolonged Outdoor Exercise in Adolescents With Type 1 Diabetes: The Artificial Pancreas Ski Study. Diabetes Care. 2017 12; 40(12):1644-1650. PMID: 28855239.
      View in: PubMed
    39. Cameron FM, Ly TT, Buckingham BA, Maahs DM, Forlenza GP, Levy CJ, Lam D, Clinton P, Messer LH, Westfall E, Levister C, Xie YY, Baysal N, Howsmon D, Patek SD, Bequette BW. Closed-Loop Control Without Meal Announcement in Type 1 Diabetes. Diabetes Technol Ther. 2017 09; 19(9):527-532. PMID: 28767276.
      View in: PubMed
    40. Messer LH, Forlenza GP, Wadwa RP, Weinzimer SA, Sherr JL, Hood KK, Buckingham BA, Slover RH, Maahs DM. The dawn of automated insulin delivery: A new clinical framework to conceptualize insulin administration. Pediatr Diabetes. 2018 Feb; 19(1):14-17. PMID: 28656656.
      View in: PubMed
    41. Huyett LM, Ly TT, Forlenza GP, Reuschel-DiVirgilio S, Messer LH, Wadwa RP, Gondhalekar R, Doyle FJ, Pinsker JE, Maahs DM, Buckingham BA, Dassau E. Outpatient Closed-Loop Control with Unannounced Moderate Exercise in Adolescents Using Zone Model Predictive Control. Diabetes Technol Ther. 2017 06; 19(6):331-339. PMID: 28459617.
      View in: PubMed
    42. Cescon M, DeSalvo DJ, Ly TT, Maahs DM, Messer LH, Buckingham BA, Doyle FJ, Dassau E. Early Detection of Infusion Set Failure During Insulin Pump Therapy in Type 1 Diabetes. J Diabetes Sci Technol. 2016 11; 10(6):1268-1276. PMID: 27621142.
      View in: PubMed
    43. Calhoun PM, Buckingham BA, Maahs DM, Hramiak I, Wilson DM, Aye T, Clinton P, Chase P, Messer L, Kollman C, Beck RW, Lum J. Efficacy of an Overnight Predictive Low-Glucose Suspend System in Relation to Hypoglycemia Risk Factors in Youth and Adults With Type 1 Diabetes. J Diabetes Sci Technol. 2016 11; 10(6):1216-1221. PMID: 27207890.
      View in: PubMed
    44. Wadwa RP, Chase HP, Raghinaru D, Buckingham BA, Hramiak I, Maahs DM, Messer L, Ly T, Aye T, Clinton P, Kollman C, Beck RW, Lum J. Ketone production in children with type 1 diabetes, ages 4-14 years, with and without nocturnal insulin pump suspension. Pediatr Diabetes. 2017 Sep; 18(6):422-427. PMID: 27402452.
      View in: PubMed
    45. Karlin AW, Ly TT, Pyle L, Forlenza GP, Messer L, Wadwa RP, DeSalvo DJ, Payne SL, Hanes S, Clinton P, Maahs DM, Buckingham B. Duration of Infusion Set Survival in Lipohypertrophy Versus Nonlipohypertrophied Tissue in Patients with Type 1 Diabetes. Diabetes Technol Ther. 2016 07; 18(7):429-35. PMID: 27227290.
      View in: PubMed
    46. DeSalvo DJ, Ly TT, Wadwa RP, Messer L, Westfall E, Gopisetty D, Hanes S, von Eyben R, Maahs DM, Buckingham BA. Continuous Glucose Sensor Survival and Accuracy Over 14 Consecutive Days. Diabetes Care. 2016 08; 39(8):e112-3. PMID: 27222506.
      View in: PubMed
    47. Ly TT, Weinzimer SA, Maahs DM, Sherr JL, Roy A, Grosman B, Cantwell M, Kurtz N, Carria L, Messer L, von Eyben R, Buckingham BA. Automated hybrid closed-loop control with a proportional-integral-derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimal performance. Pediatr Diabetes. 2017 08; 18(5):348-355. PMID: 27191182.
      View in: PubMed
    48. Messer LH, Calhoun P, Buckingham B, Wilson DM, Hramiak I, Ly TT, Driscoll M, Clinton P, Maahs DM. In-home nighttime predictive low glucose suspend experience in children and adults with type 1 diabetes. Pediatr Diabetes. 2017 08; 18(5):332-339. PMID: 27125223.
      View in: PubMed
    49. Messer L. Set for the Future. Diabetes Forecast. 2016 Mar-Apr; 69(2):81-2. PMID: 27048052.
      View in: PubMed
    50. DeSalvo DJ, Maahs DM, Messer L, Wadwa RP, Payne S, Ly TT, Buckingham BA. Effect of lipohypertrophy on accuracy of continuous glucose monitoring in patients with type 1 diabetes. Diabetes Care. 2015 Oct; 38(10):e166-7. PMID: 26307604.
      View in: PubMed
    51. Maahs DM, DeSalvo D, Pyle L, Ly T, Messer L, Clinton P, Westfall E, Wadwa RP, Buckingham B. Effect of acetaminophen on CGM glucose in an outpatient setting. Diabetes Care. 2015 Oct; 38(10):e158-9. PMID: 26269199.
      View in: PubMed
    52. Wilson DM, Calhoun PM, Maahs DM, Chase HP, Messer L, Buckingham BA, Aye T, Clinton PK, Hramiak I, Kollman C, Beck RW. Factors associated with nocturnal hypoglycemia in at-risk adolescents and young adults with type 1 diabetes. Diabetes Technol Ther. 2015 Jun; 17(6):385-91. PMID: 25761202.
      View in: PubMed
    53. Hummel K, McFann KK, Realsen J, Messer LH, Klingensmith GJ, Chase HP. The increasing onset of type 1 diabetes in children. J Pediatr. 2012 Oct; 161(4):652-7.e1. PMID: 22578579.
      View in: PubMed
    54. Taplin CE, Cobry E, Messer L, McFann K, Chase HP, Fiallo-Scharer R. Preventing post-exercise nocturnal hypoglycemia in children with type 1 diabetes. J Pediatr. 2010 Nov; 157(5):784-8.e1. PMID: 20650471.
      View in: PubMed
    55. Cobry E, McFann K, Messer L, Gage V, VanderWel B, Horton L, Chase HP. Timing of meal insulin boluses to achieve optimal postprandial glycemic control in patients with type 1 diabetes. Diabetes Technol Ther. 2010 Mar; 12(3):173-7. PMID: 20151766.
      View in: PubMed
    56. Vanderwel BW, Messer LH, Horton LA, McNair B, Cobry EC, McFann KK, Chase HP. Missed insulin boluses for snacks in youth with type 1 diabetes. Diabetes Care. 2010 Mar; 33(3):507-8. PMID: 20032279.
      View in: PubMed
    57. Kishiyama CM, Burdick PL, Cobry EC, Gage VL, Messer LH, McFann K, Chase HP. A pilot trial of pramlintide home usage in adolescents with type 1 diabetes. Pediatrics. 2009 Nov; 124(5):1344-7. PMID: 19858155.
      View in: PubMed
    58. Wadwa RP, Fiallo-Scharer R, Vanderwel B, Messer LH, Cobry E, Chase HP. Continuous glucose monitoring in youth with type 1 diabetes. Diabetes Technol Ther. 2009 Jun; 11 Suppl 1:S83-91. PMID: 19469682.
      View in: PubMed
    59. Messer L, Ruedy K, Xing D, Coffey J, Englert K, Caswell K, Ives B. Educating families on real time continuous glucose monitoring: the DirecNet navigator pilot study experience. Diabetes Educ. 2009 Jan-Feb; 35(1):124-35. PMID: 19244568.
      View in: PubMed
    60. Fox L, Dontchev M, Ruedy K, Beck R, Kollman C, Messer L, Coffey J, Wilson D, Doyle E, Tamborlane W, Steffes M. Relative inaccuracy of the A1cNow in children with type 1 diabetes. Diabetes Care. 2007 Jan; 30(1):135-7. PMID: 17192346.
      View in: PubMed
    Messer's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    Copyright © 2021 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)